首页> 外文期刊>Journal of Medical Microbiology: An Official Journal of the Pathological Society of Great Britain and Ireland >Multi-centric validation of an in-house-developed beacon-based PCR diagnostic assay kit for Chlamydia and Neisseria and portable fluorescence detector
【24h】

Multi-centric validation of an in-house-developed beacon-based PCR diagnostic assay kit for Chlamydia and Neisseria and portable fluorescence detector

机译:内部研发的用于衣原体和奈瑟菌的基于信标的PCR诊断测定试剂盒和便携式荧光检测器的多中心验证

获取原文
           

摘要

Objective. The development of an accurate, sensitive, specific, rapid, reproducible, stable-at-room-temperature and cost-effective diagnostic kit, and a low-cost portable fluorescence detector to fulfil the requirements of diagnostic facilities in developing countries.Methods. We developed the ‘Chlamy and Ness CT/NG kit’ based on molecular beacons for the detection of Chlamydia trachomatis (CT) and Neisseriagonorrhoeae (NG). Multi-centric evaluation of the CT/NG kit was performed using the commercially available nucleic acid amplification test (NAAT)-based FTD Urethritis basic kit for comparison from December 2014 to November 2016. The stability of the kit reagents at 4 and 37??C and the inter-day reproducibility of results were also analysed.Results. The sensitivity and specificity of the kit were found to be 95.83 and 100.00?% for the detection of C. trachomatis and 93.24 and 99.75?% for N. gonorrhoeae, respectively, when tested against the commercial kit. The positive predictive value (PPV) was 100.00 and 98.57?%, whereas the negative predictive value (NPV) was 99.54 and 98.79?% for C. trachomatis and N. gonorrhoeae, respectively. Analysis of the kappa statistics enhanced the ‘inter-rater’ κ=0.976 for Chlamydia and κ=0.943 for Neisseria.Conclusion. Our kit was found to be as sensitive and specific as commercially available kits. Its low cost and ease of use will make it suitable for the routine diagnosis of C. trachomatis and N. gonorrhoeae in the resource-limited settings of developing countries.
机译:目的。开发一种准确,灵敏,特异,快速,可重现,在室温下稳定且具有成本效益的诊断试剂盒和一种低成本便携式荧光检测器,以满足发展中国家诊断设施的要求。我们开发了基于分子信标的“衣原体和Ness CT / NG试剂盒”,用于检测沙眼衣原体(CT)和奈瑟氏球菌(NG)。使用市售的基于核酸扩增试验(NAAT)的FTD尿道炎基本试剂盒对CT / NG试剂盒进行多中心评估,以比较2014年12月至2016年11月。试剂盒试剂在4和37°C时的稳定性。还分析了C和结果的日间重现性。用市售试剂盒检测时,该试剂盒对检测沙眼衣原体的敏感性和特异性分别为95.83和100.00%,对淋病奈瑟氏球菌的敏感性和特异性分别为93.24和99.75%。沙眼衣原体和淋病奈瑟氏球菌的阳性预测值(PPV)分别为100.00和98.57%,而阴性预测值(NPV)分别为99.54和98.79%。对kappa统计数据的分析可提高衣原体的'inter-rater'κ= 0.976,而奈瑟氏球菌的κ= 0.943。结论。发现我们的试剂盒与市售试剂盒一样灵敏和特异。它的低成本和易用性使其适合在发展中国家资源有限的地区进行沙眼衣原体和淋病奈瑟菌的常规诊断。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号